MINI REVIEW
Accepted on 11 Jul 2025
Tumor-Infiltrating Lymphocytes in NSCLC: From Immune Surveillance to Immunotherapy
doi 10.3389/fimmu.2025.1610998
- 193 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Harnessing Molecular Insights for Enhanced Drug Sensitivity and Immunotherapy in Cancer
Harnessing Molecular Insights for Enhanced Drug Sensitivity and Immunotherapy in Cancer
19k
Total downloads
77k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 30 Jun 2025
Bioinformatics-based analysis of nicotinamide adenine dinucleotide metabolism-related genes to predict immune status and prognosis for head and neck squamous cell carcinoma patients
doi 10.3389/fimmu.2025.1609175
- 769 views
ORIGINAL RESEARCH
Published on 17 Jun 2025
Identification of anoikis-related subtypes and a risk score prognosis model, the association with TME landscapes and therapeutic responses in hepatocellular carcinoma
doi 10.3389/fimmu.2025.1602831
- 845 views
ORIGINAL RESEARCH
Published on 11 Jun 2025
Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed
doi 10.3389/fimmu.2025.1601982
- 798 views
ORIGINAL RESEARCH
Published on 10 Jun 2025
Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer
doi 10.3389/fimmu.2025.1590951
- 1,462 views
ORIGINAL RESEARCH
Published on 09 Jun 2025
TMEM115: a promising marker for glioma immunotherapy and prognosis
doi 10.3389/fimmu.2025.1598499
- 1,162 views
MINI REVIEW
Published on 02 Jun 2025
Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations
doi 10.3389/fimmu.2025.1601572
- 1,249 views
ORIGINAL RESEARCH
Published on 13 May 2025
MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation
doi 10.3389/fonc.2025.1595485
- 919 views
ORIGINAL RESEARCH
Published on 05 May 2025
TNFRSF12A expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy response
doi 10.3389/fimmu.2025.1578068
- 1,789 views
ORIGINAL RESEARCH
Published on 17 Apr 2025
The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients
doi 10.3389/fimmu.2025.1589678
- 1,569 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma
doi 10.3389/fimmu.2025.1564784
- 1,479 views
MINI REVIEW
Published on 08 Apr 2025
The role of tumor-associated macrophages in HPV induced cervical cancer
doi 10.3389/fimmu.2025.1586806
- 2,573 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore